New bio business unit for Rohm & Haas
Advanced Biosciences is a new business from Rohm & Haas dedicated to providing products and processes to enhance synthesis and purification of biopharmaceuticals. Biopharmaceuticals are drugs manufactured using fermentation, cell culture or novel synthetic processes to produce antibiotics, proteins, peptides and oligonucleotides.
This newly created business includes some of the best known Rohm & Haas products, such as Amberchrom chromatographic media, Amberlite ion exchange resins, and Amberlite XAD adsorbents. The company says it is broadening its product portfolio to include resins for upstream processes and has just introduced a new product, Ambersynth CTC resin, for solid phase synthesis of therapeutic peptides.
Mark Vander Hoff, marketing manager, Advanced Biosciences, said the new division aimed to identify, develop, and provide high value synthesis and purification solutions to biopharmaceutical manufacturers and their suppliers. The company will also utilise its capabilities in global, large-scale production to provide customers with high quality, consistent products.